These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2532753)

  • 21. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrophy of caudate nucleus in Huntington's disease measured by computed tomography.
    Roth J; Havrdová E; Růzicka E
    J Neurol; 2000 Nov; 247(11):880-1. PubMed ID: 11151423
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
    Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F
    Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease?
    Wardlaw JM; Sellar RJ; Abernethy LJ
    Neuroradiology; 1991; 33(4):316-9. PubMed ID: 1833664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single photon emission computed tomography in Huntington's chorea.
    Leblhuber F; Hoell K; Reisecker F; Gebetsberger B; Puehringer W; Trenkler E; Deisenhammer E
    Psychiatry Res; 1989 Sep; 29(3):337-9. PubMed ID: 2532751
    [No Abstract]   [Full Text] [Related]  

  • 26. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene.
    Squitieri F; Esmaeilzadeh M; Ciarmiello A; Jankovic J
    Mov Disord; 2011 Apr; 26(5):925-7. PubMed ID: 21370274
    [No Abstract]   [Full Text] [Related]  

  • 27. Obsessive-compulsive disorder in Huntington's disease.
    Cummings JL; Cunningham K
    Biol Psychiatry; 1992 Feb; 31(3):263-70. PubMed ID: 1532132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychopathology in Huntington's disease patients.
    Shiwach R
    Acta Psychiatr Scand; 1994 Oct; 90(4):241-6. PubMed ID: 7831992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional brain imaging of a catatonic type of schizophrenia: PET and SPECT studies.
    Satoh K; Narita M; Someya T; Fukuyama H; Yonekura Y
    Jpn J Psychiatry Neurol; 1993 Dec; 47(4):881-5. PubMed ID: 8201798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography.
    Künig G; Leenders KL; Sanchez-Pernaute R; Antonini A; Vontobel P; Verhagen A; Günther I
    Ann Neurol; 2000 May; 47(5):644-8. PubMed ID: 10805336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single photon emission computed tomography in subjects at risk for Huntington's chorea.
    Leblhuber F; Brucker B; Reisecker F; Steinparz F; Windhager E; Trenkler J; Deisenhammer E
    J Neurol; 1990 Dec; 237(8):496-8. PubMed ID: 2150077
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease.
    Baxter LR; Mazziotta JC; Pahl JJ; Grafton ST; St George-Hyslop P; Haines JL; Gusella JF; Szuba MP; Selin CE; Guze BH
    Arch Gen Psychiatry; 1992 Feb; 49(2):148-54. PubMed ID: 1532304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-onset Huntington's disease: a geriatric psychiatry perspective.
    Shulman KI; Lennox A; Karlinsky H
    J Geriatr Psychiatry Neurol; 1996 Jan; 9(1):26-9. PubMed ID: 8679060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT brainstem abnormalities in the differential diagnosis of Huntington's disease.
    Masucci EF; Borts FT; Kurtzke JF
    Comput Med Imaging Graph; 1990; 14(3):205-12. PubMed ID: 2140710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial psychiatric presentation of Huntington's disease.
    Lovestone S; Hodgson S; Sham P; Differ AM; Levy R
    J Med Genet; 1996 Feb; 33(2):128-31. PubMed ID: 8929949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography as an imaging tool in psychiatric disorders.
    Heiss WD; Pawlik G; Herholz K; Szelies B; Wienhard K
    Psychiatry Res; 1989 Sep; 29(3):351-2. PubMed ID: 2532752
    [No Abstract]   [Full Text] [Related]  

  • 37. Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function.
    Berent S; Giordani B; Lehtinen S; Markel D; Penney JB; Buchtel HA; Starosta-Rubinstein S; Hichwa R; Young AB
    Ann Neurol; 1988 Jun; 23(6):541-6. PubMed ID: 2970247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease.
    Kuwert T; Lange HW; Boecker H; Titz H; Herzog H; Aulich A; Wang BC; Nayak U; Feinendegen LE
    J Neurol; 1993 Nov; 241(1):31-6. PubMed ID: 8138819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathologic correlation of computerized tomography in Huntington's disease.
    Terrence CF; Rao G
    South Med J; 1980 Jun; 73(6):817-8. PubMed ID: 6446759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study.
    Turjanski N; Weeks R; Dolan R; Harding AE; Brooks DJ
    Brain; 1995 Jun; 118 ( Pt 3)():689-96. PubMed ID: 7600086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.